These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38221702)

  • 1. The Function of the Immune System, Beyond Strategies Based on Cell-Autonomous Mechanisms, Determines Cancer Development: Immune Response and Cancer Development.
    Zand H; Pourvali K
    Adv Biol (Weinh); 2024 Apr; 8(4):e2300528. PubMed ID: 38221702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.
    Casey SC; Li Y; Felsher DW
    Immunol Res; 2014 May; 58(2-3):282-91. PubMed ID: 24791942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC activation is a hallmark of cancer initiation and maintenance.
    Gabay M; Li Y; Felsher DW
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
    Cui Y; Guo G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis].
    Lunina NA; Safina DR; Kostrov SV
    Mol Biol (Mosk); 2023; 57(5):739-770. PubMed ID: 37752641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual function of MyD88 in inflammation and oncogenesis: implications for therapeutic intervention.
    Kfoury A; Virard F; Renno T; Coste I
    Curr Opin Oncol; 2014 Jan; 26(1):86-91. PubMed ID: 24285099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative interpretation of a genetic model of carcinogenesis using computer simulations.
    Dai D; Beck B; Wang X; Howk C; Li Y
    PLoS One; 2011 Mar; 6(3):e16859. PubMed ID: 21408146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis. Bystanders or bad seeds? Many autoimmune-target cells may be transforming to cancer and signalling "danger" to the immune system.
    Reines BP
    Autoimmunity; 2001; 33(2):121-34. PubMed ID: 11264791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.
    Harguindey S; Orive G; Luis Pedraz J; Paradiso A; Reshkin SJ
    Biochim Biophys Acta; 2005 Sep; 1756(1):1-24. PubMed ID: 16099110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune system and inflammation in breast cancer.
    Jiang X; Shapiro DJ
    Mol Cell Endocrinol; 2014 Jan; 382(1):673-682. PubMed ID: 23791814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Competition in Carcinogenesis.
    Madan E; Palma AM; Vudatha V; Trevino JG; Natarajan KN; Winn RA; Won KJ; Graham TA; Drapkin R; McDonald SAC; Fisher PB; Gogna R
    Cancer Res; 2022 Dec; 82(24):4487-4496. PubMed ID: 36214625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amazing roles of extrachromosomal DNA in cancer progression.
    Zhao L; Jiang Y; Lei X; Yang X
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188843. PubMed ID: 36464200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
    Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
    Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.
    Wellenstein MD; de Visser KE
    Immunity; 2018 Mar; 48(3):399-416. PubMed ID: 29562192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
    Wu D
    Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.
    Di Mitri D; Alimonti A
    Trends Cell Biol; 2016 Mar; 26(3):215-226. PubMed ID: 26564316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistemology of the origin of cancer: a new paradigm.
    Brücher BL; Jamall IS
    BMC Cancer; 2014 May; 14():331. PubMed ID: 24885752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the universe of genetic context-dependencies using mouse models of cancer.
    Falcomatà C; Bärthel S; Schneider G; Saur D; Veltkamp C
    Curr Opin Genet Dev; 2019 Feb; 54():97-104. PubMed ID: 31078084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ecDNA: A mechanism that directs tumorigenesis in cancer drug Resistance-A review.
    Ashique S; Upadhyay A; Garg A; Mishra N; Hussain A; Negi P; Hing GB; Bhatt S; Ali MK; Gowthamarajan K; Singh SK; Gupta G; Chellappan DK; Dua K
    Chem Biol Interact; 2022 Aug; 363():110000. PubMed ID: 35671828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microRNAs in metal carcinogen-induced cell malignant transformation and tumorigenesis.
    Humphries B; Wang Z; Yang C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):58-65. PubMed ID: 26903202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.